Brisbane, QLD, Australia
DSM Pharmaceutical Products is building a $65 million biologics manufacturing facility in Brisbane. The 6,500-sf project is part of the Translational Research Institute at the Princess Alexandra Hospital campus. Completion is expected by 2013.
